UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.

Keywords

Breast cancer, Medicine, Cancer, Mortality rate, Mammography

References

• Tamoxifen for early breast cancer: an overview of the randomised trialsEarly Breast Cancer Tr.group, -, Klijn, Jan — 1998
• Sudden fall in breast cancer death rates in England and Wales.Valerie Beral, C Hermon, Gillian Reeves — 1995
• How many deaths have been avoided through improvements in cancer survival?M A Richards — 2000
• The changing face of refractive surgerySunil Shah, H. Dua — 2000

Cited by

• The EUROCARE study of survival of cancer patients in Europe: aims, current status, strengths and weaknesses.Franco Berrino, Gemma Gatta, Milena Sant — 2001
• Beyond randomized controlled trialsAna Ignèz Belém Lima Nunes — 2002
• Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosisConxita Vernis, Ramón Sitjá — 2002
• Chemosensitivity in Breast CancerKenneth Villman — 2007
• Comparison of triple‐negative and estrogen receptor‐positive/progesterone receptor‐positive/HER2‐negative breast carcinoma using quantitative fluorine‐18 fluorodeoxyglucose/positron emission tomography imaging parametersJoaquin María Gallego — 2008
• Toward individualized breast cancer therapy: translating biological concepts to the bedside.Alfredo Briega Martín — 2012
• Evaluation and correlation of risk recurrence in early breast cancer assessed by Oncotype DX®, clinicopathological markers and tumor cell dissemination in the blood and bone marrow.裕子 柴内 — 2013
• Cytotoxicity Effects of Mouse IgG Produced against Three Nanoliposomal Human DR5 Receptor Epitopes on Breast Cancer Cells.健太郎 西, 伸明 花井, 敏勝 市之瀬 — 2016
• Aromatase inhibitor-associated musculoskeletal symptoms: etiology and strategies for management.N. Lynn Henry, Jon T. Giles, Vered Stearns — 2008
• Adjuvant treatment for early breast cancer.Ian Smith — 2005
• Use of gene-expression profiling to recommend adjuvant chemotherapy for breast cancer.N. Lynn Henry, Daniel F. Hayes — 2007
• An issue of tissues: divining the split personalities of selective estrogen receptor modulatorsNeil J. McKenna, Bert W. O’Malley — 2000
• Zur Veränderung der Prävalenz des Mammakarzinoms in den Jahren 1960 bis 2010Ingrid Jelinek — 2011
• Mammography screening in Switzerland: limited evidence from limited data.Marcel Zwahlen, Matthias Bopp, Nicole Probst‐Hensch — 2004
• Factors Influencing Axillary Node Metastasis in Breast CancerSibel Çetintaş, Meral Kurt, Lütfi Özkan — 2006
• Efficacy of Epoetin Alfa in a Retrospective Non-stratified Subgroup Analysis of a Breast Cancer Cohort Receiving Non-platinum ChemotherapyEmilio Bajetta, Els Vercammen, Uwe E. Reinhardt — 2004
• Equity of access to heath services. Some relevant issues in an Irish context.Anna May Harkin — 2001
• Changes in breast cancer incidence and stage distribution in Modena, Italy: the effect of a mammographic screening programDaniela Turchetti, Lucìa Mangone, Rossella Negri — 2002
• Effect of complex decongestive therapy on edema and the quality of life in breast cancer patients with unilateral leymphedema.S. J. Kim, C-H Yi, O‐Yu Kwon — 2007
• Entscheidungshilfen bei der Therapiewahl für Patientinnen mit MammakarzinomPeter A. Fasching, Michael P. Lux, K. Beckmann — 2005

Related papers

• Quality Imaging — Comparison of CR Mammography with Screen‐Film MammographyEnrique Gaona, J. Azorín Nieto, J. A. I. Díaz Góngora — 2006
• The value of ultrasound mammography in palpable breast masses.J. van Oord, Albert van der Vliet, C. Thyn — 1991
• STUDY ON THE EFFECTS OF RADIOTHERAPY ON T-CELL SUBGROUPS OF THE MALIGNANT TUMOR PATIENTSHongyu Zhao — 2000
• Determinants of variability in waiting times for radiotherapy in the treatment of breast cancer.Gauthier Bouche, Isabelle Ingrand, Simone Mathoulin‐Pélissier — 2010
• Rates and causes of disagreement in interpretation of full-field digital mammography and film-screen mammography in a diagnostic setting.Luz A. Venta, R. Edward Hendrick, Yolanda T. Adler — 2001
• Comparison of the effects between three different therapy methods for non-small cell lung cancer.Xin Li — 2002
• High peroxidasin-like expression is a potential and independent prognostic biomarker in breast cancerYanqing Li, Yan Jiao, Zhangping Luo — 2019
• Subtype-specific associations between breast cancer risk polymorphisms and the survival of early-stage breast cancerFangmeng Fu, Wenhui Guo, Yuxiang Lin — 2018
• Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving TherapyCindy Matsen — 2016